Fortis Healthcare reports 17.3% revenue rise to ₹2,559.5 crore in Q1FY27

2 min read     Updated on 07 Aug 2026, 03:41 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Fortis Healthcare Limited announced its unaudited financial results for Q1FY27, showing consolidated revenue growth of 17.3% to ₹2,559.5 crore and a slight increase in net profit to ₹272.8 crore. Standalone revenue grew to ₹508.4 crore, though net profit declined to ₹47.8 crore. The company’s debt-equity ratio improved to 0.31x on a consolidated basis.

powered bylight_fuzz_icon
47581686

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited reported a consolidated revenue from operations of ₹2,559.5 crore for the quarter ended June 30, 2026, marking a 17.3% increase from ₹2,182.1 crore in the same period last year. The company’s consolidated net profit after tax stood at ₹272.8 crore, up from ₹266.8 crore in Q1FY26. On a standalone basis, revenue grew to ₹508.4 crore from ₹473.0 crore, while net profit after tax more than doubled to ₹47.8 crore from ₹51.9 crore in the corresponding quarter of FY25, though it was significantly higher than the ₹25.0 crore reported in Q4FY26.

The filing, submitted under Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlights strong top-line growth driven by its hospital business. The company’s Managing Director & CEO, Dr. Ashutosh Raghuvanshi, certified the unaudited results. The full format of the standalone and consolidated results is available on the stock exchanges’ websites and the company’s portal.

Consolidated Financial Performance

Consolidated total income from operations reached ₹2,559.5 crore in Q1FY27, compared to ₹2,182.1 crore in Q1FY26. Net profit before tax, exceptional, and extraordinary items was ₹353.7 crore, rising from ₹337.9 crore year-on-year. After tax and exceptional items, net profit was ₹272.8 crore. Total comprehensive income for the period was ₹272.9 crore.

Metric Q1FY27 (Consolidated) Q1FY26 (Consolidated) YoY Change
Revenue from Operations ₹2,559.5 Cr ₹2,182.1 Cr +17.3%
Net Profit (After Tax) ₹272.8 Cr ₹266.8 Cr +2.2%
Total Comprehensive Income ₹272.9 Cr ₹266.3 Cr +2.5%

Note: Figures in ₹ crore. Source: Fortis Healthcare Limited financial results.

Standalone Results

On a standalone basis, Fortis Healthcare recorded revenue from operations of ₹508.4 crore, an increase from ₹473.0 crore in Q1FY26. Net profit before tax and exceptional items was ₹46.0 crore. After tax and exceptional items, net profit stood at ₹47.8 crore, compared to ₹51.9 crore in Q1FY26. Total comprehensive income was ₹47.8 crore.

Metric Q1FY27 (Standalone) Q1FY26 (Standalone) YoY Change
Revenue from Operations ₹508.4 Cr ₹473.0 Cr +7.5%
Net Profit (After Tax) ₹47.8 Cr ₹51.9 Cr -7.9%
Total Comprehensive Income ₹47.8 Cr ₹51.5 Cr -7.2%

Note: Figures in ₹ crore. Source: Fortis Healthcare Limited financial results.

Balance Sheet and Debt Metrics

As of June 30, 2026, the consolidated net worth was ₹10,190.9 crore, up from ₹9,174.9 crore in Q1FY26. Paid-up debt capital decreased to ₹2,579.7 crore from ₹2,872.7 crore at the end of FY26. The consolidated debt-equity ratio improved to 0.31 times from 0.34 times in Q4FY26. The debt service coverage ratio was 1.06 times, down from 1.24 times in the previous quarter, while the interest service coverage ratio stood at 6.91 times.

On a standalone basis, net worth increased to ₹9,306.0 crore from ₹9,123.9 crore in Q1FY26. Paid-up debt capital was ₹1,935.8 crore, slightly lower than ₹1,971.3 crore at the end of FY26. The standalone debt-equity ratio improved to 0.22 times from 0.23 times in Q4FY26.

What the Numbers Show

The divergence between consolidated revenue growth (17.3%) and net profit growth (2.2%) suggests that cost structures or integration expenses are absorbing much of the incremental revenue. However, the improvement in the debt-equity ratio to 0.31x indicates a strengthening balance sheet position. The decline in standalone net profit despite revenue growth warrants further scrutiny into segment-specific performance and operational efficiencies.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+3.82%+0.66%-2.54%+11.62%+11.30%+289.62%

What specific operational cost drivers or integration expenses are contributing to the divergence between the 17.3% revenue growth and the modest 2.2% net profit increase?

How does Fortis plan to address the decline in standalone net profit despite a 7.5% rise in standalone revenue?

Given the drop in the debt service coverage ratio from 1.24x to 1.06x, what strategies is management implementing to improve cash flow stability in the near term?

Fortis Healthcare Q1 Results: Audio recording of earnings call released

1 min read     Updated on 07 Aug 2026, 03:21 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Fortis Healthcare Limited released the audio recording of its Q1FY27 investors and analysts meet held on August 7, 2026. The call discussed unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The disclosure complies with Regulation 30 of SEBI LODR Regulations, 2015, and is available on the company's website.

powered bylight_fuzz_icon
47641874

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare has made the audio recording of its investors and analysts meet publicly available on its website. The meeting, held on Friday, August 07, 2026, at 12:00 PM (IST), focused on the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This release ensures transparency for shareholders and market participants seeking detailed insights into the Q1FY27 performance.

The disclosure was filed with the National Stock Exchange of India Ltd and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Satyendra Chauhan, Company Secretary & Compliance Officer of Fortis Healthcare Limited, signed the communication on August 07, 2026. The filing confirms that the audio recording is accessible via the company’s investor relations portal.

Key Details of the Disclosure

Parameter Details
Event Investors / Analysts Meet
Date Held August 07, 2026
Time 12:00 PM (IST)
Topic Un-audited Financial Results for Quarter Ended June 30, 2026
Regulatory Basis Regulation 30 of SEBI LODR Regulations, 2015

Accessing the Recording

Investors and analysts can access the audio recording through the official Fortis Healthcare website. The link directs users to the investor presentations and transcripts section, specifically labeled for the Q1FY27 earnings call in August 2026. This resource allows stakeholders to review management commentary and question-and-answer sessions from the event.

What the Numbers Show

While this specific filing serves as a procedural disclosure for the audio recording, it highlights the company's adherence to regulatory timelines for post-earnings communication. The focus on both standalone and consolidated results indicates a comprehensive review of the group's financial health for the period ending June 30, 2026.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+3.82%+0.66%-2.54%+11.62%+11.30%+289.62%

How will Fortis Healthcare's Q1FY27 financial performance influence its near-term expansion plans for new hospital facilities or acquisitions?

What specific operational metrics from the earnings call suggest changes in patient inflow trends compared to the previous fiscal year?

Are there any indications from management regarding potential margin pressures due to rising medical supply costs or regulatory compliance expenses in FY27?

More News on Fortis Healthcare

1 Year Returns:+11.30%